Home / Research library / Nefiracetam Powder
Nefiracetam Powder: molecular data, studies & sources
Nefiracetam Powder is catalogued here as a research compound. This profile brings together the molecular source record, selected indexed publications and available supplier comparisons. Evidence for a named substance does not authenticate a commercial product.
Compiled by PeptideTech Editors · Sources checked · Selected bibliography, not a systematic review
Molecular formula, weight & structure
- Molecular formula (MF)
- C14H18N2O2
- Molecular weight (MW)
- 246.30 g/mol
- PubChem compound ID
- 71157
- Record title
- Nefiracetam
Values describe the selected PubChem molecular entity. Counterions, salt forms, hydration and sequence changes can alter the supplied material. Confirm the exact identity against the supplier specification.
Source: PubChem CID 71157 · retrieved 2026-09-21

Chemical identifiers and source data
- IUPAC name
- N-(2,6-dimethylphenyl)-2-(2-oxopyrrolidin-1-yl)acetamide
- InChIKey
- NGHTXZCKLWZPGK-UHFFFAOYSA-N
- SMILES
- CC1=C(C(=CC=C1)C)NC(=O)CN2CCCC2=O
Human and clinical studies
Selected human-study records are shown with their indexed or reviewed study type. Check the original article for the intervention, formulation and controls; the molecule can also be a comparator or measured variable.
- Human study · PubMed trial index
Double-blind randomized treatment of poststroke depression using nefiracetam.
Robinson RG, Jorge RE, Clarence-Smith K et al. · The Journal of neuropsychiatry and clinical neurosciences · 2008
PMID 18451188 · DOI: 10.1176/jnp.2008.20.2.178
- Human study · PubMed trial index
A Randomized, Placebo-Controlled, Double-Blind Efficacy Study of Nefiracetam to Treat Poststroke Apathy.
Starkstein SE, Brockman S, Hatch KK et al. · Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association · 2016
PMID 26915605 · DOI: 10.1016/j.jstrokecerebrovasdis.2016.01.032
- Human study · PubMed trial index
Double-blind treatment of apathy in patients with poststroke depression using nefiracetam.
Robinson RG, Jorge RE, Clarence-Smith K et al. · The Journal of neuropsychiatry and clinical neurosciences · 2009
PMID 19622685 · DOI: 10.1176/jnp.2009.21.2.144
Preclinical research, reviews & other publications
Animal studies, laboratory experiments, reviews and other indexed papers answer different questions. A review is secondary evidence; a case report does not estimate how often an outcome occurs.
- Review · secondary evidence
Nefiracetam. DM 9384, DZL 221, Translon.
· Drugs in R&D · 2002
PMID 12099172 · DOI: 10.2165/00126839-200203030-00017
- Preclinical / laboratory research
Effects of the nootropic drug nefiracetam on the GABAA receptor-channel complex in dorsal root ganglion neurons.
Huang CS, Ma JY, Marszalec W et al. · Neuropharmacology · 1996
PMID 9014140 · DOI: 10.1016/s0028-3908(96)00074-3
- Preclinical / laboratory research
Nefiracetam improves Morris water maze performance following traumatic brain injury in rats.
DeFord SM, Wilson MS, Gibson CJ et al. · Pharmacology, biochemistry, and behavior · 2001
PMID 11509223 · DOI: 10.1016/s0091-3057(01)00559-7
- Review · secondary evidence
[Facilitatory actions of the cognitive enhancer nefiracetam on neuronal Ca2+ channels and nicotinic ACh receptors: their intracellular signal transduction pathways].
Yoshii M, Nishizaki T, Watabe S et al. · Nihon yakurigaku zasshi. Folia pharmacologica Japonica · 1998
PMID 10190131 · DOI: 10.1254/fpj.112.supplement_41
Nefiracetam Powder supplier sources
Scientific sources describe molecules and experiments. The commercial links below identify recorded supplier packages. A publication or chemical database entry does not verify the seller, purity, sterility or contents of a lot. Some links are affiliate links; see our disclosure.
Compare all Nefiracetam Powder sizes, forms and supplier prices →
| Supplier | Recorded packages | Example source listing |
|---|---|---|
| Amino USAUSD | 10000mg Powder1 recorded offers | 10000mg Powder · $36.00Checked Sep 16, 2026Supplier listing |
Reference sources & further reading
- PubChem compound record 71157 — chemical identity and structure.
- Wikipedia: Nefiracetam — Background encyclopedia; not a primary clinical source.
The citations above link directly to publication records. Encyclopedia links are background reading and are not used to establish clinical effectiveness.
Search for additional research
These links run searches; their results have not been individually reviewed and can include unrelated compounds.
Research information is not a dosing guide or a recommendation for personal use. Study findings are specific to the formulation, population and methods tested. Read our source and correction policy.
Related research profiles
Adalank Spray
Molecular identity needs further verification
Source verification pending
0 selected publications · 0 human study records
Adamax
Molecular identity needs further verification
Source verification pending
0 selected publications · 0 human study records
Agomelatine Powder
C15H17NO2
243.30 g/mol · PubChem CID 82148
8 selected publications · 5 human study records
Cerebrolysin
Molecular identity needs further verification
7 selected publications · 5 human study records
Dihexa
C27H44N4O5
504.7 g/mol · PubChem CID 129010512
0 selected publications · 0 human study records
Fasoracetam Powder
C10H16N2O2
196.25 g/mol · PubChem CID 198695
3 selected publications · 1 human study records